FLT3 and neoplasm: In addition, in an FLT3-ITD-positiveAML patient-derived xenograft (PDX) mouse model, the CC-90009 and quizartinibcombination showed significantly higher anti-tumor efficacy and prolongedoverall survival compared to either treatment alone.